Global NK Cell Therapy Competitive Landscape Professional Research Report 2026

According to DIResearch＇s in-depth investigation and research, the global NK Cell Therapy market size will reach 659.69 Million USD in 2026 and is projected to reach 2,111.42 Million USD by 2033, with a CAGR of 18.08% (2026-2033). Notably, the China NK Cell Therapy market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

NK cell therapy, or Natural Killer cell therapy, is an emerging form of immunotherapy that harnesses the body＇s own immune system to combat cancer and other diseases. Natural Killer (NK) cells are a type of immune cell that plays a crucial role in detecting and destroying abnormal or infected cells, including cancer cells. NK cell therapy involves the isolation and expansion of these specialized immune cells from a patient＇s own body or a donor source and their subsequent infusion into the patient. The expanded NK cells are engineered or activated to enhance their ability to recognize and target cancer cells more effectively. NK cell therapy has shown promise in various cancer treatments, providing a targeted and potent immunotherapeutic approach that can work alongside or in conjunction with other cancer therapies to combat the disease and improve patient outcomes.

The major global suppliers of NK Cell Therapy include Nektar Therapeutics, Innate Pharma, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of NK Cell Therapy. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global NK Cell Therapy market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the NK Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of NK Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of NK Cell Therapy Include:

Nektar Therapeutics

Innate Pharma

Affimed

Chipscreen Biosciences

Fate Therapeutics

Glycostem Therapeutics

Dragonfly Therapeutics

Kiadis Pharma

NantWorks

Nkarta Therapeutics

Fortress Biotech

NK Cell Therapy Product Segment Include:

NK Cell Therapies

NK Cell Directed Antibodies

NK Cell Therapy Product Application Include:

Cancer

Gastrointestinal Diseases

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global NK Cell Therapy Industry PESTEL Analysis

Chapter 3: Global NK Cell Therapy Industry Porter’s Five Forces Analysis

Chapter 4: Global NK Cell Therapy Major Regional Market Size and Forecast Analysis

Chapter 5: Global NK Cell Therapy Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global NK Cell Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table 1： Global NK Cell Therapy Market Size Growth Rate by Type, 2025 VS 2026 VS 2033 (US$ Million)

Table 2： Global NK Cell Therapy Market Size Growth Rate by Application, 2025 VS 2026 VS 2033 (US$ Million)

Table 3： NK Cell Therapy Industry Development Status

Table 4： NK Cell Therapy Industry Development Trends

Table 5： Global NK Cell Therapy Market Size by Region in US$ Million: 2025 VS 2026 VS 2033

Table 6： Global NK Cell Therapy Revenue by Region (2021-2026) & (US$ Million)

Table 7： Global NK Cell Therapy Revenue Market Share by Region (2021-2026)

Table 8： Global NK Cell Therapy Revenue Forecast by Region (2027-2033) & (US$ Million)

Table 9： Global NK Cell Therapy Revenue Market Share Forecast by Region (2027-2033)

Table 10： Global NK Cell Therapy Revenue Analysis by Type (2021-2026) & (US$ Million)

Table 11： Global NK Cell Therapy Revenue Analysis Forecast by Type (2027-2033) & (US$ Million)

Table 12： Global NK Cell Therapy Revenue Analysis by Application (2021-2026) & (US$ Million)

Table 13： Global NK Cell Therapy Revenue Analysis Forecast by Application (2027-2033) & (US$ Million)

Table 14： Key NK Cell Therapy Players in North America

Table 15： North America NK Cell Therapy Revenue by Type (2021-2026) & (US$ Million)

Table 16： North America NK Cell Therapy Revenue by Type (2027-2033) & (US$ Million)

Table 17： North America NK Cell Therapy Revenue by Application (2021-2026) & (US$ Million)

Table 18： North America NK Cell Therapy Revenue by Application (2027-2033) & (US$ Million)

Table 19： North America NK Cell Therapy Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 20： North America NK Cell Therapy Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 21： Key NK Cell Therapy Players in Europe

Table 22： Europe NK Cell Therapy Revenue by Type (2021-2026) & (US$ Million)

Table 23： Europe NK Cell Therapy Revenue by Type (2027-2033) & (US$ Million)

Table 24： Europe NK Cell Therapy Revenue by Application (2021-2026) & (US$ Million)

Table 25： Europe NK Cell Therapy Revenue by Application (2027-2033) & (US$ Million)

Table 26： Europe NK Cell Therapy Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 27： Europe NK Cell Therapy Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 28： Key NK Cell Therapy Players in China

Table 29： China NK Cell Therapy Revenue by Type (2021-2026) & (US$ Million)

Table 30： China NK Cell Therapy Revenue by Type (2027-2033) & (US$ Million)

Table 31： China NK Cell Therapy Revenue by Application (2021-2026) & (US$ Million)

Table 32： China NK Cell Therapy Revenue by Application (2027-2033) & (US$ Million)

Table 33： Key NK Cell Therapy Players in APAC (excl. China)

Table 34： APAC (excl. China) NK Cell Therapy Revenue by Type (2021-2026) & (US$ Million)

Table 35： APAC (excl. China) NK Cell Therapy Revenue by Type (2027-2033) & (US$ Million)

Table 36： APAC (excl. China) NK Cell Therapy Revenue by Application (2021-2026) & (US$ Million)

Table 37： APAC (excl. China) NK Cell Therapy Revenue by Application (2027-2033) & (US$ Million)

Table 38： APAC (excl. China) NK Cell Therapy Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 39： APAC (excl. China) NK Cell Therapy Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 40： Key NK Cell Therapy Players in Latin America

Table 41： Latin America NK Cell Therapy Revenue by Type (2021-2026) & (US$ Million)

Table 42： Latin America NK Cell Therapy Revenue by Type (2027-2033) & (US$ Million)

Table 43： Latin America NK Cell Therapy Revenue by Application (2021-2026) & (US$ Million)

Table 44： Latin America NK Cell Therapy Revenue by Application (2027-2033) & (US$ Million)

Table 45： Latin America NK Cell Therapy Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 46： Latin America NK Cell Therapy Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 47： Key NK Cell Therapy Players in Middle East & Africa

Table 48： Middle East & Africa NK Cell Therapy Revenue by Type (2021-2026) & (US$ Million)

Table 49： Middle East & Africa NK Cell Therapy Revenue by Type (2027-2033) & (US$ Million)

Table 50： Middle East & Africa NK Cell Therapy Revenue by Application (2021-2026) & (US$ Million)

Table 51： Middle East & Africa NK Cell Therapy Revenue by Application (2027-2033) & (US$ Million)

Table 52： Middle East & Africa NK Cell Therapy Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 53： Middle East & Africa NK Cell Therapy Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 54： Global NK Cell Therapy Market Revenue by Key Suppliers (2021-2026) & (US$ Million)

Table 55： Global NK Cell Therapy Revenue Market Share by Key Suppliers (2021-2026)

Table 56： Global Key Suppliers Headquarter Location and Key Area Sales

Table 57： Market Mergers & Acquisitions, Expansion

Table 58： Nektar Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 59： Nektar Therapeutics NK Cell Therapy Product Portfolio

Table 60： Nektar Therapeutics NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 61： Innate Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 62： Innate Pharma NK Cell Therapy Product Portfolio

Table 63： Innate Pharma NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 64： Affimed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 65： Affimed NK Cell Therapy Product Portfolio

Table 66： Affimed NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 67： Chipscreen Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 68： Chipscreen Biosciences NK Cell Therapy Product Portfolio

Table 69： Chipscreen Biosciences NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 70： Fate Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 71： Fate Therapeutics NK Cell Therapy Product Portfolio

Table 72： Fate Therapeutics NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 73： Glycostem Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 74： Glycostem Therapeutics NK Cell Therapy Product Portfolio

Table 75： Glycostem Therapeutics NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 76： Dragonfly Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 77： Dragonfly Therapeutics NK Cell Therapy Product Portfolio

Table 78： Dragonfly Therapeutics NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 79： Kiadis Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 80： Kiadis Pharma NK Cell Therapy Product Portfolio

Table 81： Kiadis Pharma NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 82： NantWorks Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 83： NantWorks NK Cell Therapy Product Portfolio

Table 84： NantWorks NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 85： Nkarta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 86： Nkarta Therapeutics NK Cell Therapy Product Portfolio

Table 87： Nkarta Therapeutics NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 88： Fortress Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 89： Fortress Biotech NK Cell Therapy Product Portfolio

Table 90： Fortress Biotech NK Cell Therapy Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 91： NK Cell Therapy Typical Customer List

Table 92： NK Cell Therapy Distributors List

Figure 1： NK Cell Therapy Product Pictures

Figure 2： NK Cell Therapies Picture Scope

Figure 3： NK Cell Directed Antibodies Picture Scope

Figure 4： Cancer Picture Scope

Figure 5： Gastrointestinal Diseases Picture Scope

Figure 6： Others Picture Scope

Figure 7： Global NK Cell Therapy Market Size Analysis: 2025 VS 2026 VS 2033 (US$ Million)

Figure 8： Global NK Cell Therapy Market Revenue and Growth Rate Analysis: (2021-2033) & (US$ Million)

Figure 9： Global NK Cell Therapy Market Size by Region (2021-2033) & (US$ Million)

Figure 10： Global NK Cell Therapy Market Share Scenario by Region in Percentage: 2026 Versus 2033

Figure 11： North America NK Cell Therapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 12： North America NK Cell Therapy Market Share by Players in 2025

Figure 13： North America NK Cell Therapy Revenue Market Share by Type (2021-2033)

Figure 14： North America NK Cell Therapy Revenue Market Share by Application (2021-2033)

Figure 15： US NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 16： Canada NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 17： Europe NK Cell Therapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 18： Europe NK Cell Therapy Market Share by Players in 2025

Figure 19： Europe NK Cell Therapy Revenue Market Share by Type (2021-2033)

Figure 20： Europe NK Cell Therapy Revenue Market Share by Application (2021-2033)

Figure 21： Germany NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 22： France NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 23： United Kingdom NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 24： Italy NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 25： Spain NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 26： Benelux NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 27： China NK Cell Therapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 28： China NK Cell Therapy Market Share by Players in 2025

Figure 29： China NK Cell Therapy Revenue Market Share by Type (2021-2033)

Figure 30： China NK Cell Therapy Revenue Market Share by Application (2021-2033)

Figure 31： APAC (excl. China) NK Cell Therapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 32： APAC (excl. China) NK Cell Therapy Market Share by Players in 2025

Figure 33： APAC (excl. China) NK Cell Therapy Revenue Market Share by Type (2021-2033)

Figure 34： APAC (excl. China) NK Cell Therapy Revenue Market Share by Application (2021-2033)

Figure 35： Japan NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 36： South Korea NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 37： India NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 38： Australia NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 39： Southeast Asia NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 40： Latin America NK Cell Therapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 41： Latin America NK Cell Therapy Market Share by Players in 2025

Figure 42： Latin America NK Cell Therapy Revenue Market Share by Type (2021-2033)

Figure 43： Latin America NK Cell Therapy Revenue Market Share by Application (2021-2033)

Figure 44： Mexico NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 45： Brazil NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 46： Middle East & Africa NK Cell Therapy Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 47： Middle East & Africa NK Cell Therapy Market Share by Players in 2025

Figure 48： Middle East & Africa NK Cell Therapy Revenue Market Share by Type (2021-2033)

Figure 49： Middle East & Africa NK Cell Therapy Revenue Market Share by Application (2021-2033)

Figure 50： Saudi Arabia NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 51： South Africa NK Cell Therapy Revenue (2021-2033) & (US$ Million)

Figure 52： Global NK Cell Therapy Revenue Market Share by Key Suppliers in 2025

Figure 53： Global NK Cell Therapy Industry Competition Landscape

Figure 54： NK Cell Therapy Industry Chain Analysis

Figure 55： Bottom-Up and Top-Down Research Methods

Figure 56： Key Interview Objectives

Figure 57： Data Cross Validation